# PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

> **NCT06646471** · PHASE4 · RECRUITING · sponsor: **GFPC Investigation** · enrollment: 500 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Lung Cancer

## Interventions

- **GENETIC:** Bio-bank repository
- **OTHER:** Quality of Life (QoL)
- **PROCEDURE:** G-Code

## Key facts

- **NCT ID:** NCT06646471
- **Lead sponsor:** GFPC Investigation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-26
- **Primary completion:** 2026-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646471, "PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06646471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*